Buy Side Allocation of Time: United States 2018All-America Research Team July 2, 2019 Related Articles Premium RA Capital Preps New Biotech SPAC — With an Eye on China’s Risks Stephen Taub Biotech Surge Sends Averill to the Top of February’s Market Winners Stephen Taub II Communities on Alternative Investments Sponsored by Fidelity Investments